Down-regulation of HMGB 1 induces apoptosis and inhibits invasion and migration of MCF-7 breast cancer cells through targeting SMARCC 1

High-mobility group box 1 (HMGB1) is a multifunctional protein with intranuclear and extracellular functions associated with most cancers including breast cancer. To investigate the effects of down-regulation of HMGB1 expression, MCF-7 breast cancer cells were infected with HMGB1-specific RNAi lentiviral vectors. The gene silencing effects on HMGB1 expression were subsequently confirmed by RT-PCR and western blotting analyses. HMGB1specific silencing significantly decreased cell proliferation. The impact on proliferation was observed at the cell cycle level-the number of cells in the G2/M phase increased, whereas that in G0/G1 phases decreased. Down-regulation of HMGB1 expression also increased apoptosis of MCF-7 cells, Bax/Bcl-2 ratio and Caspase-3 expression. Finally, silencing of HMGB1 expression significantly resulted in the inhibition of cellular metastatic ability and MMP-9 expression. However, these effects of HMGB1 down-regulation on proliferation, apoptosis, cell cycle and metastasis of MCF-7 cells were significantly inhibited by SMARCC1 overexpression. These findings suggest that HMGB1 is critical for the cellular survival and metastasis of breast cancer and a mechanism referred possibly through targeting SMARCC1, therefore presenting a potential therapeutic target for the treatment of breast cancer.

[1]  Kyung Jin Lee,et al.  Naringin Decreases TNF-α and HMGB1 Release from LPS-Stimulated Macrophages and Improves Survival in a CLP-Induced Sepsis Mice , 2016, PloS one.

[2]  Dong-Sun Han,et al.  Cerebral ischemic post-conditioning induces autophagy inhibition and a HMGB1 secretion attenuation feedback loop to protect against ischemia reperfusion injury in an oxygen glucose deprivation cellular model , 2016, Molecular medicine reports.

[3]  A. Miyawaki,et al.  HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer’s disease , 2016, Scientific Reports.

[4]  Mengyao Sun,et al.  Methotrexate affects HMGB1 expression in rheumatoid arthritis, and the downregulation of HMGB1 prevents rheumatoid arthritis progression , 2016, Molecular and Cellular Biochemistry.

[5]  Yun Chen,et al.  A targeted proteomics approach to the quantitative analysis of ERK/Bcl-2-mediated anti-apoptosis and multi-drug resistance in breast cancer , 2016, Analytical and Bioanalytical Chemistry.

[6]  Huiling Shen,et al.  The implication and potential applications of high-mobility group box 1 protein in breast cancer. , 2016, Annals of translational medicine.

[7]  Shun-Fa Yang,et al.  Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma , 2016, International journal of medical sciences.

[8]  Fusheng Wang,et al.  Combination of survivin siRNA with neoadjuvant chemotherapy enhances apoptosis and reverses drug resistance in breast cancer MCF-7 cells. , 2015, Journal of cancer research and therapeutics.

[9]  Xiaokun Zhao,et al.  Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway , 2015, Scientific Reports.

[10]  C. Pathak,et al.  Quercetin protects necrotic insult and promotes apoptosis by attenuating the expression of RAGE and its ligand HMGB1 in human breast adenocarcinoma cells , 2015, IUBMB life.

[11]  Cang Liu,et al.  Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[12]  F. Behbod,et al.  Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins , 2014, BMC Cancer.

[13]  J. Workman,et al.  Nucleosome remodeling by the SWI/SNF complex is enhanced by yeast high mobility group box (HMGB) proteins. , 2014, Biochimica et biophysica acta.

[14]  Shulan Zhang,et al.  Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer , 2014, International journal of molecular sciences.

[15]  Shaosong Yang,et al.  miR-200c inhibits metastasis of breast cancer cells by targeting HMGB1 , 2014, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[16]  Jie Zhang,et al.  Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus‐mediated RNA interference , 2012, Journal of cellular physiology.

[17]  B. Song,et al.  Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC‐803 gastric cancer cells , 2012, Cell biochemistry and function.

[18]  D. Sgroi,et al.  The molecular pathology of breast cancer progression , 2011, The Journal of pathology.

[19]  Po-Len Liu,et al.  High-mobility group box 1-mediated matrix metalloproteinase-9 expression in non-small cell lung cancer contributes to tumor cell invasiveness. , 2010, American journal of respiratory cell and molecular biology.

[20]  Masahide Takahashi,et al.  Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. , 2009, Cancer letters.

[21]  I. Ugrinova,et al.  Nucleosome binding properties and Co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins. , 2009, Biochemistry.

[22]  E. Perez,et al.  Treatment of metastatic breast cancer: looking towards the future , 2009, Breast Cancer Research and Treatment.

[23]  T. Ørntoft,et al.  SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation. , 2008, Histology and histopathology.

[24]  S. Fan,et al.  Growth suppression and radiosensitivity increase by HMGB1 in breast cancer , 2007, Acta Pharmacologica Sinica.

[25]  C. Peterson,et al.  Effects of HMGN1 on Chromatin Structure and SWI/SNF-mediated Chromatin Remodeling* , 2005, Journal of Biological Chemistry.

[26]  K. Tracey,et al.  High mobility group box 1 (HMGB1) , 2005, Critical care medicine.

[27]  Sheryl K Elkin,et al.  ATP-dependent Remodeling by SWI/SNF and ISWI Proteins Stimulates V(D)J Cleavage of 5 S Arrays* , 2004, Journal of Biological Chemistry.

[28]  K. Tracey,et al.  HMGB1 as a cytokine and therapeutic target , 2002, Journal of endotoxin research.

[29]  J. Minna,et al.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers , 2002, Oncogene.

[30]  P. Ahlquist,et al.  Supplemental Information CARM 1 Methylates Chromatin Remodeling Factor BAF 155 to Enhance Tumor Progression and Metastasis , 2013 .

[31]  M. Gnanasekar,et al.  Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis. , 2009, International journal of oncology.

[32]  G. Hortobagyi,et al.  Overview of resistance to systemic therapy in patients with breast cancer. , 2007, Advances in experimental medicine and biology.